PLSI — Phoenix Life Sciences International Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual income statement for Phoenix Life Sciences International, fiscal year end - February 28th, USD millions except per share, conversion factor applied.

	R2015 February 28th	2016 February 29th	2017 February 28th	2018 February 28th	2019 February 28th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	0.024	0.018	0	0	0
Cost of Revenue
Gross Profit	-0.025	0.005	0	0	-0.028
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	16.6	0.398	0.036	0	3.06
Operating Profit	-16.5	-0.38	-0.036	-0	-3.06
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-17.4	-0.788	-0.255	-0.077	-3.12
Net Income After Taxes	-17.4	-0.788	-0.255	-0.077	-3.12
Net Income Before Extraordinary Items
Net Income	-17.4	-0.788	-0.255	-0.077	-3.12
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-17.4	-0.788	-0.255	-0.077	-3.12
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-283	-33.1	-8.63	-2.46	-0.268
Dividends per Share